CA
CVS icon

Claro Advisors’s CVS Health CVS Stock Holding History

Claro Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,234
Closed -$558K – 400
2025
Q1 		$558K Buy
8,234
+3,383
+70% +$202K 0.07% 238
2024
Q4 		$218K Sell
4,851
-7,173
-60% -$402K 0.03% 447
2024
Q3 		$756K Buy
12,024
+2,563
+27% +$150K 0.1% 201
2024
Q2 		$559K Buy
9,461
+289
+3% +$18.1K 0.09% 223
2024
Q1 		$732K Buy
9,172
+1,000
+12% +$76.4K 0.13% 183
2023
Q4 		$645K Sell
8,172
-89
-1% -$6.33K 0.14% 176
2023
Q3 		$577K Buy
8,261
+337
+4% +$23.9K 0.14% 174
2023
Q2 		$548K Sell
7,924
-4,455
-36% -$317K 0.14% 183
2023
Q1 		$920K Sell
12,379
-1,864
-13% -$156K 0.27% 90
2022
Q4 		$1.33M Buy
14,243
+2,255
+19% +$218K 0.43% 55
2022
Q3 		$1.11M Hold
11,988
– – 0.44% 53
2022
Q2 		$1.11M Buy
11,988
+1,079
+10% +$105K 0.44% 53
2022
Q1 		$1.13M Hold
10,909
– – 0.4% 59
2021
Q4 		$1.13M Buy
10,909
+1,042
+11% +$96.3K 0.4% 59
2021
Q3 		$837K Sell
9,867
-6
-0.1% -$503 0.35% 73
2021
Q2 		$824K Buy
9,873
+124
+1% +$10.2K 0.37% 67
2021
Q1 		$733K Buy
9,749
+1,550
+19% +$113K 0.37% 74
2020
Q4 		$560K Buy
8,199
+1,321
+19% +$85.9K 0.3% 96
2020
Q3 		$402K Buy
6,878
+835
+14% +$52K 0.25% 113
2020
Q2 		$393K Buy
6,043
+616
+11% +$38.8K 0.27% 110
2020
Q1 		$322K Buy
5,427
+1,653
+44% +$110K 0.3% 101
2019
Q4 		$280K Sell
3,774
-561
-13% -$39.4K 0.22% 125
2019
Q3 		$273K Buy
+4,335
New +$257K 0.24% 123
2019
Q1 		– Sell
-3,557
Closed -$280K – 320
2018
Q4 		$280K Buy
+3,557
New +$266K 0.22% 99

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Claro Advisors's CVS Position: Q2 2025 in Review

Claro Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 8,234 shares — an estimated $558K sold.

Claro Advisors first reported a position in CVS in Q4 2018 and held it in 24 quarters. The position peaked at $1.33M in Q4 2022. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Claro Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Claro Advisors sold 8,234 CVS Health shares in Q2 2025, an estimated $558K.
  • Claro Advisors first reported a position in CVS Health in Q4 2018 and held it in 24 quarters.
  • Claro Advisors's CVS Health position peaked at $1.33M in Q4 2022.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Claro Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.